Random Periareolar Fine-Needle Aspiration

PROCEDURE2 trials

Sponsors

National Cancer Institute (NCI)

Conditions

Breast Atypical HyperplasiaBreast CarcinomaBreast Ductal Carcinoma In SituBreast Lobular Carcinoma In Situ

Phase 2

Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast Cancer

RecruitingNCT05941520

National Cancer Institute (NCI)Breast Atypical Hyperplasia, Breast Carcinoma, Breast Ductal Carcinoma In Situ +1

Start: 2024-08-23End: 2028-09-01Target: 80Updated: 2026-04-03

Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction

RecruitingNCT06195306

National Cancer Institute (NCI)Breast Atypical Hyperplasia, Breast Carcinoma, Breast Ductal Carcinoma In Situ +1

Start: 2025-07-28End: 2028-01-01Target: 66Updated: 2026-04-03

Related Papers

Acolbifene vs tamoxifen for breast cancer prevention in premenopausal women at high risk for breast cancer.

Journal of Clinical Oncology2025-05-28